The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma

Respiratory Medicine

Volumn 98, Issue 12, 2004, Pages 1157-1165

  Carranza Rosenzweig, Jacqueline R ^a   Edwards, Lisa ^a   Lincourt, William ^a   Dorinsky, Paul ^a   ZuWallack, Richard L ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Correlation study; Lung function tests; Quality of life; Retrospective study; Symptoms

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CORRELATION ANALYSIS; DISEASE CONTROL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ASTHMA; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 8644280544     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.04.001     Document Type: Article

References (37)

1. CDC. Surveillance for asthma-United States, 1980-99. MMWR 2002;51(SS01):1-13
2. American Lung Association. Trends in Asthma Morbidity and Mortality. February 2002. http://www.lungusa.org/data/asthma/ASTHMAdt.pdf
3. Juniper E.F. Guyatt G.H. Ferrie P.J. Griffith L.E. Measuring quality of life in asthma Am Rev Respir Dis 147 1993 832-838
4. Wolfe J. Rooklin A. Grady J. et al. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids J Allergy Clin Immunol 105 6 I 2000 1153-1161
5. ZuWallack R. Adelglass J. Clifford D.P. et al. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma Chest 118 2 2000 303-312
6. Gross G. Wolfe J. Noonan M. Pinnas J.L. et al. Differential effects of inhaled corticosteroids: Fluticasone propionate versus triamcinolone acetonide Am J Manag Care 4 1998 233-244
7. Condemi J.J. Chervinsky P. Goldstein M.F. et al. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma J Allergy Clin Immunol 100 4 1997 467-474
8. Raphael G.D. Lanier R.Q. Baker J. Edwards L. Rickard K. Lincourt W.R. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma J Allergy Clin Immunol 103 5 I 1999 796-803
9. Baraniuk J, Murray JJ, Nathan RA, Berger, et al. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest 1999;116(3):625-32
10. Busse W. Wolfe J. Storms W. et al. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: A randomized, double-blind, placebo-controlled trial J Fam Pract 50 7 2001 595-602
11. Busse W. Raphael G.D. Galant S. Kalberg C. et al. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical-trial J Allergy Clin Immunol 107 3 2001 461-468
12. Meltzer E.O. Lockey R.F. Friedman B.F. et al. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma Mayo Clin Proc 77 5 2002 437-445
13. Berger W. Ford L.B. Mar T. et al. Efficacy and safety of fluticasone propionate 250 micrograms administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids Ann Allergy Asthma Immunol 89 4 2002 393-399
14. Pearlman DS, White MV, Lieberman, et al. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol 2002;88(2):227-35
15. Calhoun W.J. Nelson H.S. Nathan R.A. et al. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta-agonists alone Am J Respir Crit Care Med 164 5 2001 759-763
16. Kavuru M, Melamed J, Gross G, LaForce, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105(6 I):1108-16
17. Shapiro G. Lumry W. Wolfe J. et al. Combined salmeterol 50 mug and fluticasone propionate 250 in the diskus device for the treatment of asthma Am J Respir Crit Care Med 161 2 I 2000 527-534
18. Wolfe J, Kreitzer S, Chervinsky, et al. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma. Ann Allergy Asthma Immunol 2000;84(3):334-40
19. Kemp J.P. Cook D.A. Incaudo G.A. et al. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids J Allergy Clin Immunol 101 2 I 1998 188-195
20. Wenzel S.E. Lumry W. Manning M. et al. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma Ann Allergy Asthma Immunol 80 6 1998 463-470
21. Busse W.W. Casale T.B. Murray J.J. Petrocella V. Cox F. Rickard K. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma Am J Manag Care 4 11 1998 1579-1587
22. Lockey R.F. DuBuske L.M. Friedman B. Petrocella V. Cox F. Rickard K. Nocturnal asthma: Effect of salmeterol on quality of life and clinical outcomes Chest 115 3 1999 666-673
23. Condemi J.J. Goldstein S. Kalberg C. et al. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma Ann Allergy Asthma Immunol 82 4 1999 383-389
24. Guidelines for the Evaluation of Impairment/disability in patients with asthma. Am Rev Respir Dis 1993;147:1056-61
25. American Thoracic Society: Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:1285-98
26. Crapo R.O. Morris A.H. Gardner R.M. Reference spirometric values using techniques and equipment that meets ATS recommendations Am Rev Respir Dis 123 1981 659-664
27. Polgar G. Promadhat V. Pulmonary function testing in children: techniques and standards 1971 WB Saunders Philadelphia
28. Juniper E.F. Guyatt G.H. Epstein R.S. Ferrie P.J. Evaluation of impairment of health-related quality of life in asthma: Development of a questionnaire for use in clinical trials Thorax 47 1992 76-83
29. Leidy N.K. Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample Qual Life Res 7 1998 127-134
30. Juniper E.F. Johnston P.R. Barkhoff C.M. et al. Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol Am J Respir Crit Care 151 1995 66-70
31. Juniper E.F. Svensson K. O'Byrne P.M. et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol Eur Respir J 14 1999 1038-1043
32. Juniper E.F. Wisniewski M.E. Cox F.M. Emmett A.H. Nielsen K.E. O'Byrne P.M. Relationship between quality of life and clinical status in asthma: A factor analysis Eur Respir J 23 2004 287-291
33. National Heart, Lung, and Blood Institute. Expert Panel 2: Guidelines for the diagnosis and management of asthma. Publication No.97-4051, National Institutes of Health, April 1997, Bethesda, MD
34. Charlton I. Charlton G. Broomfield J. Mullee M.A. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice Br Med J 301 1990 1355-1359
35. Moy M.L. Israel E. Weiss S.T. et al. Clinical predictors of health-related quality of life depend on asthma severity Am J Respir Crit Care Med 163 2001 924-929
36. Van der Molen T. Postma D.S. Schreurs A.J.M. Bosveld H.E.P. Sears M.R. Meyboom de Jong B. Discriminative aspects of two generic and two asthma-specific instruments: Relation with symptoms, bronchodilators use and lung function in patients with mild asthma Qual Life Res 6 4 1997 353-361
37. Apter A.J. Affleck G. Reisine S.T. et al. Perception of airway obstruction in asthma: Sequential daily analyses of symptoms peak expiratory flow rate, and mood J Allergy Clin Immunol 99 5 1997 605-612